PDGFRB (Tyr751) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-PDGFRB (Tyr751) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | PDGFRB (Tyr751) |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | mouse, rat |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mg |
| Concentration | 1 mg/ml |
| Applications | Western Blot (WB), Immunohistochemistry (IHC), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: PDGFRB antibody (Tyr751) detects endogenous levels of PDGFR beta only when phosphorylated at tyrosine 751. PDGFRB binds members of the platelet-derived growth factor family. The identity of the growth factor bound determines whether the functional receptor is a homodimer or a heterodimer, composed of both PDGFR-alpha and -beta. Ligand binding induces receptor dimerization and autophosphorylation, thereby recruiting SH2-containing proteins including Grb2, Src, GAP, PTPN11, PI3 kinase, PLC-gamma and Nck. |
| Immunogen | Immunogen: PDGFRB antibody was raised in Rabbit using a synthesized phosphopeptide derived from human PDGFR beta around the phosphorylation site of tyrosine 751 (V-D-YP-V-P) as the immunogen. |
| Other Names | [Rabbit PDGFRB (Tyr751); PDGFRB; PDGFRB; Beta-type platelet-derived growth factor receptor; CD140 antigen-like family member B; CD140B; JTK12; PDGF-R-beta; PDGFR; PDGFR1; PDGFRB; PGFRB; platelet-derived growth factor receptor beta polypeptide] |
| Gene, Accession # | [PDGFRB], Gene ID: 5159, UniProt: P09619 |
| Catalog # | MBS5313761 |
| Price | $375 |
| Order / More Info | PDGFRB (Tyr751) Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies